Jason O'Byrne, EVP & Chief Financial Officer at Vir Biotechnology, Inc. (VIR), sold 2,089 shares at $7.45 ($16K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Scheduled sale ($16k) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |